"We Envision Growth Strategies Most Suited
to Your Business"

Hearing Aids Market to Grow at a CAGR of 10.1% During the Projected Period; Growing Number of Individuals Suffering from Hearing Loss to Propel Market Growth

July 23, 2025 | Healthcare

The global hearing aids market size was valued at USD 13.97 billion in 2024. The market is projected to grow from USD 15.11 billion in 2025 to USD 29.58 billion by 2032, exhibiting a CAGR of 10.1% during the forecast period.

Fortune Business Insights™ presents this information in its report titled, "Hearing Aids Market Size, Share & Industry Analysis, By Product (Hearing Devices (BTE {Behind the Ear}, ITE {In the Ear}, RIC {Receiver in the Canal}, CIC {Completely in the Canal}, and Others) and Hearing Implants (Cochlear Implants and Bone-anchored Implants)), By Patient Type (Adult and Pediatric), By Technology (Digital and Analog), By Severity (Mild, Moderate, and Severe & Profound), By Type of Hearing Loss (Sensorineural, Conductive, and Mixed), By Distribution Channel (OTC, Medical Channel, and Private Practices), and Regional Forecast, 2025-2032"

A medical electronic device that helps people who suffer from hearing loss is referred to as a hearing aid. Occurrences of hearing impairment and loss are typically prevalent among geriatric patients is growing, resulting in a crucial factor for a boost in the demand for hearing aids. Growing occurrences of mild or moderate hearing loss are leading to increased focus by the key players on research and development activities to develop and launch new hearing devices.

Notable Player to Focus on Strategic Product Launches to Fuel Market Development

In August 2024, two novel platforms under the company's brand, namely Phonak: Infinio and Audeo Sphere Infinio, were introduced by Sonova with the object to assist in the development of hearing devices which are integrated with advanced technology in the market.

Rising Prevalence of Hearing Loss among Older Adults to Drive Market Growth

One of the main causes of the rising diagnostic and treatment rate among patients is the rising prevalence of partial and total hearing loss. Since hearing loss is more common in older adults, the aging population is another factor contributing to the rising number of patients with the condition. In addition, number of factors have been identified as potential causes of hearing loss in the general population, including hereditary vulnerability, noise exposure, vascular problems, and chronic ear inflammation.

However, limitations, including a lack of awareness regarding the advantages that the hearing devices come with, coupled up with disposable income rates being lower among the lower-income nations, are hindering the hearing aids market growth.

Prominent Players Focus on Introducing Cutting-Edge Hearing-Aids Device to Foster Market Growth

There are limited notable players in the market that hold a major share in the hearing aids market share. Major players, including Sonova, Demant A/S, and WS Audiology, are employing strategies such as research and development activities to introduce new products; as a result, players are securing a strong footprint in the hearing aid market. Moreover, companies including GN Store Nord A/S, Cochlear Ltd., and Starkey Laboratories Inc. are directed toward introducing products that are integrated with cutting-edge technology, resulting in effective and precise products available to the patient population.

Notable Industry Development

  • February 2025: Pure Charge&Go BCT IX hearing devices, which are a smart device with Bluetooth connectivity, were launched by WS Audiology with an intend to fortify its product portfolio.

List of the Companies Profiled in the Report

  • Starkey Laboratories Inc. (U.S.)
  • WS Audiology (Denmark)
  • GN Store Nord A/S (Denmark)
  • Cochlear Ltd. (Australia)
  • RION Co., Ltd. (Japan)
  • Sonova (Switzerland)
  • Demant A/S (Denmark)
  • MED-EL (Medical Electronics) (Austria)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/hearing-aids-market-101573

Further Report Findings

  • North America's dominance is attributed to an increasing demand for integration of cutting-edge technology in hearing devices, robust governing provisions, and substantial adoption rate of hearing devices, which are among many factors anticipated to fuel the growth of the market in the region.
  • The highest CAGR growth of the market in Asia Pacific is propelled by the growing incidences of geriatric population suffering from hearing impairment and loss, leading to a rise in diagnosis rate, in turn contributing to the demand in Asia Pacific for hearing devices.
  • Based on product, the hearing devices segment led the largest market share, owing to an increase in awareness regarding the advantages of hearing devices, including canal hearing aids, among others, coupled with the major players focusing on R&D activities to launch advanced hearing devices.
  • In terms of patient type, the adult segment held the largest market share. The rising demand for diagnostic and treatment services is supported by an increasing occurrence of hearing loss among adults.

Table of Segmentation

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 10.1% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Product

  • Hearing Devices
    • BTE (Behind the Ear)
    • ITE (In the Ear)
    • RIC (Receiver in the Canal)
    • CIC (Completely in the Canal)
    • Others
  • Hearing Implants
    • Cochlear Implants
    • Bone Anchored Implants

By Patient Type

  • Adult
  • Pediatric

By Technology

  • Digital
  • Analog

By Severity

  • Mild
  • Moderate
  • Severe & Profound

By Type of Hearing Loss

  • Sensorineural
  • Conductive
  • Mixed

By Distribution Channel

  • OTC
  • Medical Channel
  • Private Practices

By Region

  • North America (By Product, Patient Type, Severity, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Patient Type, Severity, Distribution Channel, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Patient Type, Severity, Distribution Channel, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Product, Patient Type,  Severity, and Distribution Channel)

Healthcare
  • PDF
  • 2024
  • 2019 - 2023
  • 139

    CHOOSE LICENSE TYPE

  • 4850
    5850
    6850

Our Clients

 Kpmg
 LG Chem
 Mckinsey
 Mobil
 uniliver